NVAX FY 2019 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena

NVAXNovavax, Inc.

$2B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$19M-45.6% YoY

Gross Profit

-$95M-510.0% margin

Operating Income

-$121M-646.1% margin

Net Income

-$130M-697.1% margin

EPS (Diluted)

$-5.40

Cash Flow

Operating Cash Flow

-$137M

Free Cash Flow

-$138M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$173M

Total Liabilities

$359M

Stockholders' Equity

-$186M

Cash & Equivalents

$79M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$34M	-45.6%
Gross Profit	-$95M	$34M	-377.6%
Operating Income	-$121M	-$174M	+30.7%
Net Income	-$130M	-$185M	+29.6%